Diasorin SpA (LTS:0GZX) Net Interest Margin (Bank Only) %


LTS:0GZX Diasorin SpA LTS:0GZX
78 GF Score
Price €69.31
GF Value €90.95
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Diasorin SpA Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

LTS:0GZX
78GF Score
Diasorin SpA LTS:0GZX
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Diasorin SpA (LTS:0GZX) Overvalued in 2026?

Based on GuruFocus' analysis, Diasorin SpA stock appears to be undervalued. The current stock price of €69.31 is trading 23.8% below its estimated GF Value™ of €90.95. GuruFocus considers Diasorin SpA to be Modestly Undervalued.

Key valuation signals for LTS:0GZX:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €90.95 vs. price of €69.31 (23.8% below fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the LTS:0GZX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diasorin SpA Business Description

Address Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Diasorin develops and manufactures a broad portfolio of in vitro diagnostics for detecting pathogens and sample contamination from the human body, as well as for use in industrial settings, such as food and water contamination testing. The company operates three segments: immunodiagnostics (69% of sales), molecular diagnostics (16%), and licensed technologies (14%). Diasorin was an important manufacturer of covid tests, which boosted its profits during the pandemic, but this segment's importance has decreased over the years, and in 2025, it accounted for only 1% of total sales.
78GF Score

Get the complete analysis for LTS:0GZX

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€69.31
Price
€90.95
GF Value